Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 2/2014

01-03-2014 | Original Article

Preliminary evidence of early bone resorption in a sheep model of acute burn injury: an observational study

Authors: Gordon L. Klein, Yixia Xie, Yi-Xian Qin, Liangjun Lin, Minyi Hu, Perenlei Enkhbaatar, Lynda F. Bonewald

Published in: Journal of Bone and Mineral Metabolism | Issue 2/2014

Login to get access

Abstract

Treatment with bisphosphonates within the first 10 days of severe burn injury completely prevents bone loss. We therefore postulated that bone resorption occurs early post burn and is the primary explanation for acute bone loss in these patients. Our objective was to assess bone for histological and biomechanical evidence of early resorption post burn. We designed a randomized controlled study utilizing a sheep model of burn injury. Three sheep received a 40 % total body surface area burn under isoflurane anesthesia, and three other sheep received cotton-smoke inhalation and served as control. Burned sheep were killed 5 days post procedure and controls were killed 2 days post procedure. Backscatter scanning electron microscopy was performed on iliac crests obtained immediately postmortem along with quantitative histomorphometry and compression testing to determine bone strength (Young’s modulus). Blood ionized Ca was also determined in the first 24 h post procedure as was urinary CTx. Three of three sheep killed at 5 days had evidence of scalloping of the bone surface, an effect of bone resorption, whereas none of the three sheep killed at 2 days post procedure had scalloping. One of the three burned sheep killed at 5 days showed quantitative doubling of the eroded surface and halving of the bone volume compared to sham controls. Mean values of Young’s modulus were approximately one third lower in the burned sheep killed at 5 days compared to controls, p = 0.08 by unpaired t test, suggesting weaker bone. These data suggest early post-burn bone resorption. Urine CTx normalized to creatinine did not differ between groups at 24 h post procedure because the large amounts of fluids received by the burned sheep may have diluted urine creatinine and CTx and because the urine volume produced by the burned sheep was threefold that of the controls. We calculated 24 h urinary CTx excretion, and with this calculation CTx excretion/24 h in the burned sheep was nearly twice that of the controls. Moreover, whole blood ionized Ca measured at 3- to 6-h intervals over the first 24 h in both burn and control sheep showed a 6 % reduction versus baseline in the burned sheep with <1 % reduction in the control animals. This sheep model was previously used to demonstrate upregulation of the parathyroid calcium-sensing receptor within the timeframe of the present study. Because both early bone resorption, supported by this study, and calcium-sensing receptor upregulation, consistent with the observed reduction in blood ionized Ca, are mediated by proinflammatory cytokines that are present as part of the post-burn systemic inflammatory response, we may postulate that post-burn upregulation of the parathyroid calcium-sensing receptor may be an adaptive response to clear the blood of excess calcium liberated by cytokine-mediated bone resorption.
Literature
1.
go back to reference Klein GL, Nicolai M, Langman CB, Cuneo BF, Sailer DE, Herndon DN (1997) Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion. J Pediatr 131:246–251PubMedCrossRef Klein GL, Nicolai M, Langman CB, Cuneo BF, Sailer DE, Herndon DN (1997) Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion. J Pediatr 131:246–251PubMedCrossRef
2.
go back to reference Klein GL, Wimalawansa SJ, Kulkarni G, Sherrard DJ, Sanford AP, Herndon DN (2005) The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study. Osteoporos Int 16:631–635PubMedCrossRef Klein GL, Wimalawansa SJ, Kulkarni G, Sherrard DJ, Sanford AP, Herndon DN (2005) The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study. Osteoporos Int 16:631–635PubMedCrossRef
3.
go back to reference Klein GL, Herndon DN, Rutan TC et al (1993) Bone disease in burn patients. J Bone Miner Res 8:337–345PubMedCrossRef Klein GL, Herndon DN, Rutan TC et al (1993) Bone disease in burn patients. J Bone Miner Res 8:337–345PubMedCrossRef
4.
go back to reference Klein GL, Herndon DN, Goodman WG et al (1995) Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone (NY) 17:455–460CrossRef Klein GL, Herndon DN, Goodman WG et al (1995) Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone (NY) 17:455–460CrossRef
5.
go back to reference Przkora R, Herndon DN, Sherrard DJ, Chinkes DL, Klein GL (2007) Pamidronate preserves bone mass for at least two years following acute administration for pediatric burn injury. Bone (NY) 41:297–302CrossRef Przkora R, Herndon DN, Sherrard DJ, Chinkes DL, Klein GL (2007) Pamidronate preserves bone mass for at least two years following acute administration for pediatric burn injury. Bone (NY) 41:297–302CrossRef
6.
go back to reference Klein GL, Bi LX, Sherrard DJ et al (2004) Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int 15:468–474PubMedCrossRef Klein GL, Bi LX, Sherrard DJ et al (2004) Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int 15:468–474PubMedCrossRef
7.
go back to reference Murphey ED, Chattopadhyay N, Bai M et al (2000) Up-regulation of the parathyroid calcium sensing receptor after burn injury in sheep: a potential contributory factor to post-burn hypocalcemia. Crit Care Med 28:3885–3890PubMedCrossRef Murphey ED, Chattopadhyay N, Bai M et al (2000) Up-regulation of the parathyroid calcium sensing receptor after burn injury in sheep: a potential contributory factor to post-burn hypocalcemia. Crit Care Med 28:3885–3890PubMedCrossRef
8.
go back to reference Klein GL, Langman CB, Herndon DN (2002) Vitamin D depletion following burn injury in children: a possible factor in post-burn osteopenia. J Trauma 52:346–350PubMedCrossRef Klein GL, Langman CB, Herndon DN (2002) Vitamin D depletion following burn injury in children: a possible factor in post-burn osteopenia. J Trauma 52:346–350PubMedCrossRef
9.
go back to reference Leblebici B, Sezgin N, Ulusan SN, Tarim AM, Akman MN, Haberal MA (2008) Bone loss during the acute stage following burn injury. J Burn Care Res 29:763–767PubMedCrossRef Leblebici B, Sezgin N, Ulusan SN, Tarim AM, Akman MN, Haberal MA (2008) Bone loss during the acute stage following burn injury. J Burn Care Res 29:763–767PubMedCrossRef
10.
go back to reference Chavassieux P, Garnero P, Duboueuf F et al (2001) Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: a biochemical, histomorphometric, and densitometric study. J Bone Miner Res 16:89–96PubMedCrossRef Chavassieux P, Garnero P, Duboueuf F et al (2001) Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: a biochemical, histomorphometric, and densitometric study. J Bone Miner Res 16:89–96PubMedCrossRef
11.
go back to reference Nielsen PK, Rasmussen AK, Butters R et al (1997) Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium sensing receptor mRNA. Biochem Biophys Res Commun 238:880–885PubMedCrossRef Nielsen PK, Rasmussen AK, Butters R et al (1997) Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium sensing receptor mRNA. Biochem Biophys Res Commun 238:880–885PubMedCrossRef
12.
go back to reference Toribio RE, Kohn CW, Capen CC, Rosol TJ (2003) Parathyroid hormone (PTH) secretion, PTH mRNA, and calcium-sensing receptor mRNA expression in equine parathyroid cells, and effects of interleukin (IL)-1, IL-6, and tumor necrosis factor alpha on equine parathyroid cell function. J Mol Endocrinol 31:609–620PubMedCrossRef Toribio RE, Kohn CW, Capen CC, Rosol TJ (2003) Parathyroid hormone (PTH) secretion, PTH mRNA, and calcium-sensing receptor mRNA expression in equine parathyroid cells, and effects of interleukin (IL)-1, IL-6, and tumor necrosis factor alpha on equine parathyroid cell function. J Mol Endocrinol 31:609–620PubMedCrossRef
13.
go back to reference Canaff L, Zhou X, Hendy GN (2008) The pro-inflammatory cytokine interleukin-6 up-regulates calcium-sensing receptor gene transcription via Stat 1/3 and Sp 1/3. J Biol Chem 283:13586–13600PubMedCrossRef Canaff L, Zhou X, Hendy GN (2008) The pro-inflammatory cytokine interleukin-6 up-regulates calcium-sensing receptor gene transcription via Stat 1/3 and Sp 1/3. J Biol Chem 283:13586–13600PubMedCrossRef
Metadata
Title
Preliminary evidence of early bone resorption in a sheep model of acute burn injury: an observational study
Authors
Gordon L. Klein
Yixia Xie
Yi-Xian Qin
Liangjun Lin
Minyi Hu
Perenlei Enkhbaatar
Lynda F. Bonewald
Publication date
01-03-2014
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 2/2014
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-013-0483-4

Other articles of this Issue 2/2014

Journal of Bone and Mineral Metabolism 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.